The U.S. Food and Drug Administration ( FDA) has placed an immediate clinical hold on Sarepta Therapeutics' investigational ...

Scientists have used an AI model to reassess the results of a completed clinical trial for an Alzheimer's disease drug. They found that the drug slowed cognitive decline by 46% in a group of patients ...

Scientists have used an AI model to reassess the results of a completed clinical trial for an Alzheimer's disease drug.

Eli Lilly's donanemab gets CHMP backing for early Alzheimer's in select patients after trials show reduced disease ...

A man with one of the deadliest forms of brain cancer is now hopeful for the future after his tumor completely disappeared ...

Participants in trials of BrainStorm Cell Therapeutics' NurOwn filed a Citizens’ Petition with the FDA earlier this month ...

Health professionals and advocates shared experiences and insights on the critical importance of Black participation in ...

Man with deadly glioblastoma shows no signs of disease after taking experimental immunotherapy drug ipilimumab, inspiring a ...

A recent study found that only 15% of cancer survivors discussed trials with their healthcare providers, with ...

With few treatments available to treat Alzheimer’s disease, scientists have turned to cancer drugs as a potential means of ...

For patients unable to withstand the increased toxicity of a four-drug regimen, the two most commonly used triplet regimens ...

Karen Peterson was diagnosed with stage 1 triple-negative breast cancer that quickly returned as stage 4. Joining a clinical ...